Patent Assignment
Reel/Frame 052368/0355
Assignment of Assignor's Interest
Recorded: 2020-04-10
Pages: 4
Assignee
CLOUDBREAK THERAPEUTICS, LLC
15615 ALTON PARKWAY, SUITE 450, IRVINE, CALIFORNIA, 92618
Covered Property
(1)
Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization
PCT:
PCT/US2017/034795 ↗
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.